On this page:OverviewFunded papers
ScholarIQanswers from OpenAlex

Sarepta Therapeutics

FunderResearch funding and supported work

Sarepta Therapeutics is a funder indexed in ScholarIQ from OpenAlex.

What is known about Sarepta Therapeutics?

ScholarIQrecord summary

biopharmaceutical company

How many works does Sarepta Therapeutics have?

ScholarIQindexed works

Sarepta Therapeutics has 772 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Sarepta Therapeutics?

ScholarIQopenalex

The OpenAlex for Sarepta Therapeutics is on the source record.

What is the ROR of Sarepta Therapeutics?

ScholarIQror

The ROR for Sarepta Therapeutics is on the source record.

What are the most-cited papers on Sarepta Therapeutics?

ScholarIQmost cited works
Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF
Carly Adamson, Kieran F. Docherty, Hiddo J.L. Heerspink, Rudolf A. de Boer, Kevin Damman, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Mark C. Petrie, Piotr Ponikowski, Marc S. Sabatine, Morten Schou, Scott D. Solomon, Subodh Verma, Olof Bengtsson, Anna Maria Langkilde, Mikaela Sjöstrand, Muthiah Vaduganathan, Pardeep S. Jhund, John J.V. McMurray
Circulation. 2022133 CitationsOPEN ACCESS
470M+ articles · 14-day free trial